good sleuthing
@jcurveto reply to
@fatbuuoyBOD are now looking at shareholders as a 'nuisance' - how dare they organize and motivate against Pfizer offer ! Disgrace.
Any new information, advances, etc have to pass several tests, one of which - does this 'news' provide a positive or negative effect on the company ? There is no quantum. If something has occurred, that could have an effect of the company, then under continuous disclosure rules of the ASX and ASIC, the information needs to be promulgated, whether this is market sensitive or not. It is not for the shareholders to find out what is happening, it is the duty of a board member of a publicly listed company to do so. By not doing so, then there are few conclusions to be drawn :-
a - The BOD are taking the shareholders for granted - a very dangerous game to play.
b- there could be some positives in the information as dug up by
@jcurve in which may well be positive, but BOD do not want this promulgated as this could (even though separate to Pfizer) may cause some more s/h to reject the 'scheme'.
c- BOD are too busy working out how to minimize their capital gains once they shaft the shareholders and walk away, instead of actually doing what they should be, and running the company for the best interests of shareholders.
So a,b or c...(or d and e - someone will surely add) - or is it 'a' 'b' and 'c'?
